CHIMERIX INC. - COMMON STOCK

Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference

28 Feb 2023 15:05:01 By Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023

23 Feb 2023 06:00:01 By Nasdaq GlobeNewswire

Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference

05 Jan 2023 06:00:00 By Nasdaq GlobeNewswire

Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update

08 Dec 2022 16:00:00 By Nasdaq GlobeNewswire

Chimerix Responds to Rubric Capital Management

10 Nov 2022 15:30:00 By Nasdaq GlobeNewswire

Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update

03 Nov 2022 06:00:02 By Nasdaq GlobeNewswire

Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022

27 Oct 2022 15:30:00 By Nasdaq GlobeNewswire

Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions

26 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 Sep 2022 06:00:01 By Nasdaq GlobeNewswire

Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox

29 Aug 2022 09:45:00 By Nasdaq GlobeNewswire

Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update

08 Aug 2022 15:01:00 By Nasdaq GlobeNewswire

Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs

08 Aug 2022 06:00:00 By Nasdaq GlobeNewswire

Chimerix to Present at Wedbush PacGrow Healthcare Conference

02 Aug 2022 06:00:01 By Nasdaq GlobeNewswire

Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022

01 Aug 2022 15:01:00 By Nasdaq GlobeNewswire

Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada

24 Jun 2022 09:06:16 By Nasdaq GlobeNewswire

Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement

23 Jun 2022 08:15:16 By Nasdaq GlobeNewswire

Chimerix to Present at Jefferies Global Healthcare Conference

01 Jun 2022 15:30:00 By Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright Global Investment Conference

17 May 2022 15:15:00 By Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update

16 May 2022 06:00:01 By Nasdaq GlobeNewswire

Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties

16 May 2022 05:30:00 By Nasdaq GlobeNewswire